Welcome Guest User | Login or Register

Investor Relations

Investor Relations

STERIS plc is a leading provider of infection prevention and procedural products and services, focused primarily on the critical markets of healthcare, pharmaceutical and research and medical devices. Our mission is to help our Customers create a healthier and safer world by providing innovative healthcare and life science product and service solutions around the globe.

NYSE   |   STE (common stock)
$111.25 + 1.59
Stock chart for: STE.  Currently trading at $111.25 with a 52 week high of $121.67 and a 52 week low of $82.88.
01/16/19 4:02 p.m. ET
Data provided by Nasdaq. Minimum 15 minutes delayed.

Recent Press Releases

STERIS to Present at the J.P. Morgan Healthcare Conference

Read More

STERIS Announces Targeted Restructuring Plan

Read More

STERIS Announces Financial Results for Fiscal 2019 Second Quarter

Read More

Investor Events

Monday, January 7, 2019 
3:00 p.m. PT
STERIS plc at the JP Morgan Healthcare Conference
Wednesday, November 7, 2018 
1:45 p.m. ET
STERIS plc at Stephens Fall Investment Conference